Chromos Licenses Cellular Engineering Tech to Pfizer
Chromos Molecular Systems said last week that it will non-exclusively license to Pfizer its ACE System to develop cell lines for research, development, and manufacturing of Pfizer products.
The licensing agreement expands upon an original agreement announced in December, under which Chromos is using the ACE System to engineer cell lines to express a Pfizer protein. Pfizer will continue to support this work, Chromos said.
Financial terms of the deal were not disclosed.